Head of Research, Krungthai XSpring

Waraporn Wiboonkanarak

Head of Research

A full service Thai brokerage

Krungthai XSpring

Krungthai XSpring is a full service broker. The company provides a wide range of investment services such as Securities Brokerage, Derivative Agent Business, Securities Borrowing and Lending, Securities Trading, Underwriting, Financial Advisory, Wealth Advisory, Private Fund Management and International Markets Securities Trading. 

In terms of credibility, Fitch Ratings has assigned Krunghtai XSpring a long-term rating of AA- and a national short-term rating of F1+ with stable outlook.

Thematic (Sector/Industry)

<ul><li>Although the market faced no negative catalysts, profit-taking — coupled with selling pressure from domestic funds and foreign investors — pulled the SET lower.</li><li>Technically, the index has been moving along the uptrend line resistance and remains above all short-term EMA lines.</li><li>We recommend selective speculation, as the upward trend remains intact.</li></ul>

Although the market faced no negative catalysts, profit-taking — coupled with selling pressure from domestic funds and foreign investors — pulled the SET lower.Technically, the index has been moving along the uptrend line resistance and remains above all short-term EMA lines.We recommend selective speculation, as the upward trend remains intact.

Krungthai XSpring Technical Eng. August 15, 2025

<ul><li>The SET surged in line with other Asian bourses, buoyed by expectations of a Fed rate cut and the MPC’s 0.25% policy rate reduction.</li><li>The index rebounded sharply and advanced further, supported by rising RSI and MACD, and remains above all short-term EMA lines.</li><li>We recommend selective speculation as the index continues to advance with the potential to rally towards the 1,300-point level.</li></ul>

The SET surged in line with other Asian bourses, buoyed by expectations of a Fed rate cut and the MPC’s 0.25% policy rate reduction.The index rebounded sharply and advanced further, supported by rising RSI and MACD, and remains above all short-term EMA lines.We recommend selective speculation as the index continues to advance with the potential to rally towards the 1,300-point level.

Krungthai XSpring Technical Eng. August 14, 2025

Global Healthcare Analyst

Tina Banerjee

Equity Bottom-Up

Bumrungrad Hospital Pub Co / Equity Bottom-Up

<ul>
<li>
<a href="https://www.smartkarma.com/entities/bumrungrad-hospital-pub-co" target="_blank" data-smartkarma-citation="entities:883:1" rel="noopener">Bumrungrad Hospital Pub Co (BH TB)</a> reported lower hospital revenue, down by 4% YoY to THB 6,104M in 2Q25 (down 5% in 1H25 to THB 12,125M).</li>
<li>Revenue contribution from international patients stayed at 64% with price competition impacting negatively amid volumes growth from markets like Middle east.</li>
<li>Maintaining stable margins with cost control would be key for the company amid revenue softness.</li>
</ul>



Bumrungrad Hospital Pub Co (BH TB) reported lower hospital revenue, down by 4% YoY to THB 6,104M in 2Q25 (down 5% in 1H25 to THB 12,125M).
Revenue contribution from international patients stayed at 64% with price competition impacting negatively amid volumes growth from markets like Middle east.
Maintaining stable margins with cost control would be key for the company amid revenue softness.


Bumrungrad Hospital (BH TB): International Sale Still Not Out of Woods, Margin Improve Sequentially

<ul><li>The SET moved up and down in a narrow range, as the market lacked new catalysts.</li><li>However, political instability and the uncertainty surrounding trade negotiations between the US and Thailand stimulated a selling force, particularly targeting DELTA, which caused the index to close down slightly, even though the banking, ICT, commerce, and energy sectors improved.</li><li>The index has not yet formed a negative price pattern, as it continues to climb steadily—positioning itself to potentially test the resistance level at 1,116 points.</li></ul>

The SET moved up and down in a narrow range, as the market lacked new catalysts.However, political instability and the uncertainty surrounding trade negotiations between the US and Thailand stimulated a selling force, particularly targeting DELTA, which caused the index to close down slightly, even though the banking, ICT, commerce, and energy sectors improved.The index has not yet formed a negative price pattern, as it continues to climb steadily—positioning itself to potentially test the resistance level at 1,116 points.

<ul><li>The SET initially faced profit-taking pressure after a rapid rally.</li><li>However, the index only experienced a slight pullback, supported by gains in ADVANC, DELTA, and AOT, which helped cushion the decline.</li><li>Additionally, the ceasefire agreement between Israel and Iran provided further support.</li></ul>

The SET initially faced profit-taking pressure after a rapid rally.However, the index only experienced a slight pullback, supported by gains in ADVANC, DELTA, and AOT, which helped cushion the decline.Additionally, the ceasefire agreement between Israel and Iran provided further support.

Thailand

Praram 9 Hospital PCL operates as a hospital. The Hospital provides medical services that includes, check-ups, diagnoses, skin care, rehabilitation, X-ray, and surgeries, as well as treatment of joint diseases, kidney, high blood pressure, cancer, diabetes, neurology, vertigo, and headache. Praram 9 Hospital serves patients in Thailand.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Praram 9 Hospital PCL (PR9 TB)

Krungthai XSpring Technical Eng. August 15, 2025

Although the market faced no negative catalysts, profit-taking — coupled with selling pressure from domestic funds and foreign investors — pulled...

Krungthai XSpring

Krungthai XSpring Technical Eng. August 14, 2025

The SET surged in line with other Asian bourses, buoyed by expectations of a Fed rate cut and the MPC’s 0.25% policy rate reduction.

Krungthai XSpring

Bumrungrad Hospital (BH TB): International Sale Still Not Out of Woods, Margin Improve Sequentially

Bumrungrad Hospital reported lower hospital revenue and significant margin expansion in 2Q25. Maintaining stable margins with cost control would...

Tina Banerjee

Technical Analysis - JUNE 27, 2025

The index has not yet formed a negative price pattern, as it continues to climb steadily—positioning itself to potentially test the resistance...

Krungthai XSpring

Technical Analysis - JUNE 26, 2025

The SET initially faced profit-taking pressure after a rapid rally. However, the index only experienced a slight pullback, supported by gains in...

Krungthai XSpring

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Krungthai XSpring Technical Eng. August 15, 2025

Although the market faced no negative catalysts, profit-taking — coupled with selling pressure from domestic funds and foreign investors — pulled...

Krungthai XSpring

Krungthai XSpring Technical Eng. August 14, 2025

The SET surged in line with other Asian bourses, buoyed by expectations of a Fed rate cut and the MPC’s 0.25% policy rate reduction.

Krungthai XSpring

Bumrungrad Hospital (BH TB): International Sale Still Not Out of Woods, Margin Improve Sequentially

​Bumrungrad Hospital reported lower hospital revenue and significant margin expansion in 2Q25. Maintaining stable margins with cost control would...

Tina Banerjee

Technical Analysis - JUNE 27, 2025

The index has not yet formed a negative price pattern, as it continues to climb steadily—positioning itself to potentially test the resistance...

Krungthai XSpring

Technical Analysis - JUNE 26, 2025

The SET initially faced profit-taking pressure after a rapid rally. However, the index only experienced a slight pullback, supported by gains in...

Krungthai XSpring

Bumrungrad Hospital reported lower hospital revenue and significant margin expansion in 2Q25. Maintaining stable margins with cost control would...